Mon, October 31, 2022

Joseph Pantginis Maintained (ATNM) at Strong Buy with Increased Target to $53 on, Oct 31st, 2022

Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Increased Target from $45 to $53 on, Oct 31st, 2022.

Joseph has made no other calls on ATNM in the last 4 months.



There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $20 on, Thursday, September 8th, 2022